AMANDA DALLAS: Open Payments
NPI 1447938600 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 46 payments from 15 companies in 2025. Trend: 2023 $340 · 2024 $969 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $324 |
| Novo Nordisk Inc | 9 | $188 |
| Lilly USA, LLC | 10 | $153 |
| PFIZER INC. | 4 | $76 |
| Abbott Laboratories | 3 | $69 |
| Exact Sciences Corporation | 3 | $52 |
| Boston Scientific Corporation | 2 | $47 |
| Astellas Pharma US Inc | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: AIRSUPRA, MOUNJARO, BREZTRI, Ozempic, FARXIGA, FREESTYLE LIBRE 3, Rybelsus, ELIQUIS.
Industry payments across TN — which companies pay providers there.
